We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Heron Therapeutics Takes Shot at FDA After CRL Stalls Anti-Pain Treatment
Heron Therapeutics Takes Shot at FDA After CRL Stalls Anti-Pain Treatment
Heron Therapeutics on Wednesday said they were sandbagged by federal regulators who issued a complete response letter for the company’s experimental anti-pain medicine.